Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, 3rd Edition
This guideline informs clinical, public health, and research laboratories on susceptibility testing of infrequently isolated or fastidious bacteria that are not included in CLSI documents M02, M07, or M100. Antimicrobial agent selection, test interpretation, and quality control are addressed.
Member pricing between $54.00 and $153.00Nonmember Price: $180.00
Chairholder: Janet A. Hindler, MCLS, MT(ASCP) and Sandra S. Richter, MD, D(ABMM)
Date of Publication: October 2, 2015
ISBN Number: 1-56238-917-3
Order Code PDF: M45Ed3E
Order Code Print: M45Ed3
M45 Additional Details
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.